Xinling Yang

1.1k total citations
67 papers, 784 citations indexed

About

Xinling Yang is a scholar working on Neurology, Molecular Biology and Neurology. According to data from OpenAlex, Xinling Yang has authored 67 papers receiving a total of 784 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Neurology, 27 papers in Molecular Biology and 19 papers in Neurology. Recurrent topics in Xinling Yang's work include Parkinson's Disease Mechanisms and Treatments (29 papers), Nuclear Receptors and Signaling (15 papers) and Neuroinflammation and Neurodegeneration Mechanisms (10 papers). Xinling Yang is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (29 papers), Nuclear Receptors and Signaling (15 papers) and Neuroinflammation and Neurodegeneration Mechanisms (10 papers). Xinling Yang collaborates with scholars based in China, United States and Malaysia. Xinling Yang's co-authors include Qin Luo, Pingyi Xu, Yousheng Xiao, Pengfei Wang, Luan Cen, Shaogang Qu, Shuxuan Huang, Shaomin Li, Runsheng Chen and Jianjun Luo and has published in prestigious journals such as PLoS ONE, Biochemistry and Small.

In The Last Decade

Xinling Yang

62 papers receiving 767 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xinling Yang China 14 313 273 201 154 131 67 784
Lei Wei China 17 353 1.1× 247 0.9× 140 0.7× 215 1.4× 79 0.6× 38 761
Tian Liu China 15 564 1.8× 172 0.6× 95 0.5× 192 1.2× 107 0.8× 35 978
Maohong Cao China 14 326 1.0× 164 0.6× 77 0.4× 117 0.8× 80 0.6× 49 631
Gye Sun Jeon South Korea 18 506 1.6× 250 0.9× 129 0.6× 241 1.6× 83 0.6× 47 891
Axel Freischmidt Germany 16 616 2.0× 692 2.5× 254 1.3× 128 0.8× 139 1.1× 35 1.2k
Fabrizio Pontarelli United States 12 514 1.6× 379 1.4× 183 0.9× 410 2.7× 124 0.9× 17 1.1k
Ekaterina Savchenko Finland 15 254 0.8× 121 0.4× 207 1.0× 119 0.8× 74 0.6× 41 812
Kaori Kawai Japan 17 532 1.7× 441 1.6× 114 0.6× 106 0.7× 77 0.6× 27 980
Julien Couthouis United States 16 595 1.9× 418 1.5× 249 1.2× 186 1.2× 45 0.3× 22 1.1k
Scott Pownall Canada 8 427 1.4× 368 1.3× 122 0.6× 269 1.7× 51 0.4× 8 816

Countries citing papers authored by Xinling Yang

Since Specialization
Citations

This map shows the geographic impact of Xinling Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinling Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinling Yang more than expected).

Fields of papers citing papers by Xinling Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinling Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinling Yang. The network helps show where Xinling Yang may publish in the future.

Co-authorship network of co-authors of Xinling Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Xinling Yang. A scholar is included among the top collaborators of Xinling Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xinling Yang. Xinling Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ding, Liuyan, Minshan Chen, Xiaobei Wang, et al.. (2025). Rhapontigenin attenuates neurodegeneration in a parkinson’s disease model by downregulating mtDNA-cGAS-STING-NF-κB-mediated neuroinflammation via PINK1/DRP1-dependent microglial mitophagy. Cellular and Molecular Life Sciences. 82(1). 337–337. 4 indexed citations
2.
Kuang, Yaoyun, Hengxu Mao, Minshan Chen, et al.. (2024). α-Synuclein seeding amplification assays for diagnosing synucleinopathies: an innovative tool in clinical implementation. Translational Neurodegeneration. 13(1). 56–56. 5 indexed citations
3.
Kuang, Yaoyun, Hengxu Mao, Tingting Gan, et al.. (2024). A skin-specific α-Synuclein seeding amplification assay for diagnosing Parkinson’s disease. npj Parkinson s Disease. 10(1). 129–129. 13 indexed citations
4.
Ma, Richard, et al.. (2024). Treatment of intracranial aneurysms with pipeline embolization device: a single-center experience. Quantitative Imaging in Medicine and Surgery. 14(4). 2916–2926.
5.
Wang, Zihao, et al.. (2024). Investigating the Genetic Association of 40 Biochemical Indicators with Parkinson’s Disease. Journal of Molecular Neuroscience. 74(4). 92–92. 1 indexed citations
6.
Wang, Zihao, et al.. (2024). No association between genetically predicted vitamin D levels and Parkinson’s disease. PLoS ONE. 19(11). e0313631–e0313631. 2 indexed citations
7.
Meng, X. Wei, et al.. (2023). Dyrk1a Phosphorylation of α-Synuclein Mediating Apoptosis of Dopaminergic Neurons in Parkinson’s Disease. Parkinson s Disease. 2023. 1–13. 5 indexed citations
8.
Ma, Richard, et al.. (2023). Endovascular re-canalization for symptomatic non-acute intracranial large artery occlusion: a single-center retrospective study. Quantitative Imaging in Medicine and Surgery. 13(12). 8031–8041.
9.
Zhang, Wenlong, Junwei Gong, Liuyan Ding, et al.. (2020). Functional validation of a human GLUD2 variant in a murine model of Parkinson’s disease. Cell Death and Disease. 11(10). 897–897. 18 indexed citations
10.
Wang, Yuling, et al.. (2020). Principal component analysis of routine blood test results with Parkinson's disease: A case-control study. Experimental Gerontology. 144. 111188–111188. 13 indexed citations
11.
Chen, Pei, Yan Feng, Kexin Li, et al.. (2019). FGF-21 ameliorates essential hypertension of SHR via baroreflex afferent function. Brain Research Bulletin. 154. 9–20. 9 indexed citations
12.
Mo, Mingshu, Guihua Li, Congcong Sun, et al.. (2018). Dopaminergic neurons show increased low-molecular-mass protein 7 activity induced by 6-hydroxydopamine in vitro and in vivo. Translational Neurodegeneration. 7(1). 19–19. 10 indexed citations
13.
Li, Peishan, Yali Yao, Qin Luo, Huan Xia, & Xinling Yang. (2017). Association between ATP13A2 gene Ala746Thr, Thr12Met and familial Parkinson’s disease. Zhonghua shiyan waike zazhi. 34(2). 304–307. 1 indexed citations
14.
Cen, Luan, Shuxuan Huang, Miaomiao Zhou, et al.. (2017). Peripheral Lymphocyte Subsets as a Marker of Parkinson’s Disease in a Chinese Population. Neuroscience Bulletin. 33(5). 493–500. 44 indexed citations
15.
Wang, Yuling, et al.. (2015). [Related factors and prevalence for the essential tremor disease of Uygur residents in Hetian, Xinjiang UygurAutonomous Region].. PubMed. 95(1). 69–72. 3 indexed citations
16.
Li, Xiaoxia, Qin Liao, Huan Xia, & Xinling Yang. (2015). Association between Parkinson's disease and G2019S and R1441C mutations of the LRRK2 gene. Experimental and Therapeutic Medicine. 10(4). 1450–1454. 8 indexed citations
17.
Yang, Xinling. (2013). Analysis of prevalence and related factors in different national Pakinson′s disease in Yili of Xinjiang area. Xinjiang Yike Daxue xuebao. 1 indexed citations
18.
Yang, Xinling. (2012). Correlation between LRRK2 gene S1647T polymorphism and Parkinson′s disease in Xinjiang Uygur and Han Nationalities. Yixue yanjiusheng xuebao. 1 indexed citations
19.
Yang, Xinling. (2009). Clinical study of the changing of bodyweight(BW)and fasting blood glucose(FBG)in obese patients with type 2 diabetes on a low-carbohydrate diet(LCD). Xinjiang Yike Daxue xuebao. 4 indexed citations
20.
Wang, Yuling, et al.. (2009). Pramipexole combined with Madopar vs Madopar alone for treatment of Parkinson's disease: a randomized controlled clinical trial. Chinese Journal of Neuromedicine. 8(7). 685–689. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lei Wei Breakdown of academic impact, for papers by Tian Liu Breakdown of academic impact, for papers by Maohong Cao Breakdown of academic impact, for papers by Gye Sun Jeon Breakdown of academic impact, for papers by Axel Freischmidt Breakdown of academic impact, for papers by Fabrizio Pontarelli Breakdown of academic impact, for papers by Ekaterina Savchenko Breakdown of academic impact, for papers by Kaori Kawai Breakdown of academic impact, for papers by Julien Couthouis Breakdown of academic impact, for papers by Scott Pownall
Rankless by CCL
2026